Mirae Asset Global ETFs Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19M	Sell	63,265 -18,060	-22%	-$5.45M	0.02%	515
2026 Q1	$26.9M	Buy	81,325 +1,224	+2%	+$417K	0.04%	397
2025 Q4	$31.9M	Buy	80,101 +69,430	+651%	+$30.7M	0.05%	348
2025 Q3	$4.86M	Sell	10,671 -887	-8%	-$361K	0.01%	817
2025 Q2	$3.76M	Sell	11,558 -2,395	-17%	-$663K	0.01%	826
2025 Q1	$3.76M	Sell	13,953 -778	-5%	-$200K	0.01%	851
2024 Q4	$3.47M	Sell	14,731 -11,081	-43%	-$2.91M	0.01%	879
2024 Q3	$7.1M	Sell	25,812 -5,481	-18%	-$1.43M	0.02%	669
2024 Q2	$7.62M	Buy	+31,293	New	+$4.94M	0.02%	621

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ALNY Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Alnylam Pharmaceuticals (ALNY) stake by 22% in Q2 2026, selling an estimated $5.45M and leaving 63,265 shares worth $19M. The position accounts for 0.02% of the portfolio, ranked #515.

Mirae Asset Global ETFs Holdings first reported a position in ALNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $31.9M in Q4 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Mirae Asset Global ETFs Holdings held 63,265 shares of Alnylam Pharmaceuticals worth $19M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 18,060 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $5.45M.
Alnylam Pharmaceuticals made up 0.02% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #515 holding.
Mirae Asset Global ETFs Holdings first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Alnylam Pharmaceuticals position peaked at $31.9M in Q4 2025.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.